Literature DB >> 9806528

Prostate target volume variations during a course of radiotherapy.

J A Antolak1, I I Rosen, C H Childress, G K Zagars, A Pollack.   

Abstract

PURPOSE: The purpose of this study was to measure the mobility of the clinical target volume (CTV) in prostate radiotherapy with respect to the pelvic anatomy during a course of therapy. These data are needed to properly design the planning target volume (PTV). METHODS AND MATERIALS: Seventeen patients were studied. Each patient underwent computed tomography (CT) scanning for treatment planning purposes. Subsequently, three CT scans were obtained at approximately 2-week intervals during treatment. The prostate, seminal vesicles, bladder, and rectum were outlined on each CT study. The second through the fourth CT studies were aligned with the first study using a rigid body transformation based on the bony anatomy. The transformation was used to compute the center of mass position and bounding box of each organ in the subsequent studies relative to the first study. Differences in the bounding box limits and center of mass positions between the first and subsequent studies were tabulated and correlated with bladder and rectal volume and positional parameters.
RESULTS: The mobility of the CTV was characterized by standard deviations of 0.09 cm (left-right), 0.36 cm (cranial-caudal), and 0.41cm (anterior-posterior). Prostate mobility was not significantly correlated with bladder volume. However, the mobility of both the prostate and seminal vesicles was very significantly correlated with rectal volume. Bladder and rectal volumes decreased between the pretreatment CT scan and the first on-treatment CT scan, but were constant for all on-treatment CT scans.
CONCLUSION: Margins between the CTV and PTV based on the simple geometric requirement that a point on the edge of the CTV is enclosed by the PTV 95% of the time are 0.7 cm in the lateral and cranial-caudal directions, and 1.1 cm in the anterior-posterior direction. However, minimum dose to the CTV and avoidance of organs at risk are more important considerations when drawing beam apertures. More consistent methods for reproducing prostate position (e.g., empty rectum) and more sophisticated beam aperture optimization are needed to guarantee consistent coverage of the CTV while avoiding organs at risk.

Entities:  

Mesh:

Year:  1998        PMID: 9806528     DOI: 10.1016/s0360-3016(98)00248-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  31 in total

1.  Impact of double-balloon rectal catheter use in external-beam radiotherapy for prostate cancer.

Authors:  Kenji Takayama; Takashi Mizowaki; Yoshiharu Negoro; Yoshiki Norihisa; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-05       Impact factor: 3.402

Review 2.  Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Authors:  Alan Pollack; Alex Hanlon; Eric M Horwitz; Steven Feigenberg; Robert G Uzzo; Robert A Price
Journal:  World J Urol       Date:  2003-09-05       Impact factor: 4.226

3.  A method to evaluate dose errors introduced by dose mapping processes for mass conserving deformations.

Authors:  C Yan; G Hugo; F J Salguero; N Saleh-Sayah; E Weiss; W C Sleeman; J V Siebers
Journal:  Med Phys       Date:  2012-04       Impact factor: 4.071

4.  A pseudoinverse deformation vector field generator and its applications.

Authors:  C Yan; H Zhong; M Murphy; E Weiss; J V Siebers
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

5.  Assessing the daily consistency of bladder filling using an ultrasonic Bladderscan device in men receiving radical conformal radiotherapy for prostate cancer.

Authors:  S Hynds; C K McGarry; D M Mitchell; S Early; L Shum; D P Stewart; J A Harney; C R Cardwell; J M O'Sullivan
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

6.  Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer.

Authors:  Su Yu Zhu; Takashi Mizowaki; Yoshiki Norihisa; Kenji Takayama; Yasushi Nagata; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

7.  The effect of concurrent androgen deprivation and 3D conformal radiotherapy on prostate volume and clinical organ doses during treatment for prostate cancer.

Authors:  C Onal; E Topkan; E Efe; M Yavuz; G Arslan; A Yavuz
Journal:  Br J Radiol       Date:  2009-07-06       Impact factor: 3.039

8.  Changes in rectal volume and prostate localization due to placement of a rectum-emptying tube.

Authors:  Hiroshi Fuji; Shigeyuki Murayama; Masashi Niwakawa; Raizou Yamaguchi; Ryou Yamashita; Takashi Matsui; Haruo Yamashita; Tetsuo Nishimura; Kenichi Tobisu
Journal:  Jpn J Radiol       Date:  2009-06-25       Impact factor: 2.374

9.  Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers.

Authors:  David Skarsgard; Pat Cadman; Ali El-Gayed; Robert Pearcey; Patricia Tai; Nadeem Pervez; Jackson Wu
Journal:  Radiat Oncol       Date:  2010-06-10       Impact factor: 3.481

10.  cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancer.

Authors:  Peter F Orio; Gregory S Merrick; Zachariah A Allen; Wayne M Butler; Kent E Wallner; Brian S Kurko; Robert W Galbreath
Journal:  Radiat Oncol       Date:  2009-07-22       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.